On July 25, 2018, CMS proposed changes that would encourage site-neutral payment between sites of services and make healthcare prices more transparent for patients so that they can be more informed about out-of-pocket costs.
The Centers for Medicare & Medicaid (CMS) has proposed revisions to the Medicare Advantage program and prescription drug benefit program (Part D) that would implement new benefits under the Affordable Care Act and increase patient protections.
Medicare beneficiaries enrolled in Medicare health and prescription drug plans will continue to have a wide range of plan options in 2010, and those beneficiaries who decide to change plans should find choosing a new plan simpler than in previous years.
The Centers for Medicare & Medicaid Services (CMS) today announced a national strategy for monitoring claims for the drugs epoetin alfa (Epogen®) and darbepoetin alfa (Aranesp®) for anemia management in patients with End Stage Renal Disease (ESRD) and who are dialyzed in renal facilities.
The Centers for Medicare & Medicaid Services (CMS) expects to pay approximately $56.5 billion to 875,000 physicians and other health care professionals in 2006, according to a proposed rule released today that would update payment rates and revise payment policies under the Medicare Physician Fee Schedule.